Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study

被引：1
|
作者：
Broadhurst, P. [1 ]
Toyoda, H. [2 ]
Kumada, T. [2 ]
Schweitzer, N. [3 ]
Vogel, A. [3 ]
Benckert, J. [4 ]
Berg, T. [4 ]
Best, J. [5 ]
Dechene, A. [5 ]
Weinmann, A. [6 ,7 ]
Galle, P. [6 ]
Yeo, W. [8 ]
Chan, S. L. [8 ]
Berhane, S. [9 ]
Palmer, D. [9 ]
Cross, T. [10 ]
Stern, N. [11 ]
Reeves, H. [12 ,13 ]
Johnson, P. [9 ,14 ]
机构：
[1] Univ Liverpool, Sch Med, Liverpool, Merseyside, England
[2] Ogaki Municipal Hosp, Gastroenterol & Hepatol, Ogaki, Gifu, Japan
[3] Hannover Med High Sch, Clin Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[4] Univ Hosp, Sect Hepatol, Gastroenterol & Rheumatol, Leipzig, Germany
[5] Univ Duisburg Essen, Univ Hosp Essen, Gastroenterol & Hepatol, Essen, Germany
[6] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Med 1, Mainz, Germany
[7] Johannes Gutenberg Univ Mainz, Univ Med Ctr, CRU, Mainz, Germany
[8] Chinese Univ Hong Kong, Hong Kong Canc Inst, Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[9] Univ Liverpool, Mol & Clin Canc Med, Liverpool, Merseyside, England
[10] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Hepatol, Liverpool, Merseyside, England
[11] Aintree Univ Hosp NHS Fdn Trust, Digest Dis Unit, Liverpool, Merseyside, England
[12] Freeman Rd Hosp, Newcastle Upon Tyne NHS Fdn Trust, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[13] Freeman Rd Hosp, Newcastle Upon Tyne NHS Fdn Trust, Hepatopancreatobiliary Multidisciplinary Team, Newcastle Upon Tyne, Tyne & Wear, England
[14] Clatterbridge Canc Ctr NHS Fdn Trust, Wirral, Merseyside, England
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31684-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-078
引用
收藏
页码：S620 / S621
页数：2
相关论文
共 50 条
  • [1] Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein
    Nouso, Kazuhiro
    Kobayashi, Yoshiyuki
    Nakamura, Shinichiro
    Kobayashi, Sayo
    Takayama, Hiroki
    Toshimori, Junichi
    Kuwaki, Kenji
    Hagihara, Hiroaki
    Onishi, Hideki
    Miyake, Yasuhiro
    Ikeda, Fusao
    Shiraha, Hidenori
    Takaki, Akinobu
    Iwasaki, Yoshiaki
    Kobashi, Haruhiko
    Yamamoto, Kazuhide
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (07) : 1195 - 1200
  • [2] Prognostic implication of serum alpha-fetoprotein in patients with unresectable hepatocellular carcinoma treated with regorafenib
    Lim, D-H.
    Casadei-Gardini, A.
    Lee, M. A.
    Lonardi, S.
    Kim, J. W.
    Masi, G.
    Chon, H. J.
    Rimini, M.
    Kim, I.
    Cheon, J.
    Hwang, J-E.
    Kang, J. H.
    Lim, H. Y.
    Yoo, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S827 - S827
  • [3] The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients
    Silva, Jack P.
    Gorman, Richard A.
    Berger, Nicholas G.
    Tsai, Susan
    Christians, Kathleen K.
    Clarke, Callisia N.
    Mogal, Harveshp
    Gamblin, T. Clark
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (07) : 831 - 840
  • [4] Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
    Wei, Zhewen
    Zhang, Yizhou
    Lu, Haizhen
    Ying, Jianming
    Zhao, Hong
    Cai, Jianqiang
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (04) : 669 - 677
  • [5] Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment
    Mazza, Stefano
    Frigerio, Chiara
    Alfieri, Daniele
    Mauro, Aurelio
    Torello Viera, Francesca
    Scalvini, Davide
    Barteselli, Chiara
    Sgarlata, Carmelo
    Veronese, Letizia
    Bardone, Marco
    Rovedatti, Laura
    Agazzi, Simona
    Strada, Elena
    Pozzi, Lodovica
    Maestri, Marcello
    Ravetta, Valentina
    Anderloni, Andrea
    MEDICINA-LITHUANIA, 2024, 60 (05):
  • [6] FUCOSYLATION OF SERUM ALPHA-FETOPROTEIN IN PATIENTS WITH PRIMARY HEPATOCELLULAR-CARCINOMA
    AOYAGI, Y
    ISEMURA, M
    YOSIZAWA, Z
    SUZUKI, Y
    SEKINE, C
    ONO, T
    ICHIDA, F
    BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 830 (03) : 217 - 223
  • [7] SERUM ALPHA-FETOPROTEIN AS A BIOCHEMICAL MARKER FOR HEPATOCELLULAR CARCINOMA
    MCINTIRE, KR
    PRINCLER, GL
    VOGEL, CL
    PATEL, IR
    CANCER RESEARCH, 1972, 32 (09) : 1941 - &
  • [8] The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma
    Sun, Li-Yue
    Cen, Wen-Jian
    Zeng, Xin-Xin
    Zhong, Yu-Yun
    Deng, Ling
    Yang, Jiao-Jiao
    Li, Ming
    Wang, Fang
    AMERICAN SURGEON, 2024, 90 (06) : 1240 - 1249
  • [9] Alpha-fetoprotein and hepatocellular carcinoma
    Colli, Agostino
    Fraquelli, Mirella
    Conte, Dario
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (08): : 1939 - 1939
  • [10] PIVKA-II AS A PROGNOSTIC FACTOR FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA AND WITH NORMAL SERUM ALPHA-FETOPROTEIN LEVELS
    Ho, Chun-Ting
    Tan, Elise Chia-Hui
    Ma, Tzu-Han
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    Wu, Jaw-Ching
    Su, Chien-Wei
    HEPATOLOGY, 2024, 80
12345